Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beyond Diabetes: Abbott Launches Glucose Sport Biosensor For Athletes To Track Blood Sugar

Executive Summary

Analyst Larry Biegelsen expects Abbott’s CGM move into the consumer market could open a large new marketing opportunity.

You may also be interested in...



Abbott Expands Lingo Bio-wearables Line From Measuring Glucose To Ketone, Lactate, Alcohol

Abbott announced at CES 2022 it is developing a line of consumer wearables, starting with a device to track ketones continuously, which is expected to launch in Europe this year. 

Market Intel: Glucose Monitor Market Set To Explode As Patients Access Better Devices

The market for blood glucose monitoring devices is expected to see double-digit growth, reaching $19.7bn by 2025. This growth is driven largely by the rising demand for smaller, more convenient continuous glucose monitoring (CGMs) devices with improved digital capabilities.

JPM 2021: Boston Scientific, Abbott, Dexcom, Insulet, Silk Road Medical

The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the second day of the meeting.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT142759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel